Literature DB >> 32997075

Risk factors for eating disorders: an umbrella review of published meta-analyses.

Marco Solmi1,2,3, Joaquim Radua3,4,5, Brendon Stubbs6,7,8, Valdo Ricca9, Davide Moretti9, Daniele Busatta9, Andre F Carvalho10,11, Elena Dragioti12, Angela Favaro1,2, Alessio Maria Monteleone13, Jae Il Shin14, Paolo Fusar-Poli3,15,16, Giovanni Castellini9.   

Abstract

OBJECTIVE: To grade the evidence about risk factors for eating disorders (anorexia nervosa, bulimia nervosa, and binge eating disorder) with an umbrella review approach.
METHODS: This was a systematic review of observational studies on risk factors for eating disorders published in PubMed/PsycInfo/Embase until December 11th, 2019. We recalculated random-effect meta-analyses, heterogeneity, small-study effect, excess significance bias and 95% prediction intervals, grading significant evidence (p < 0.05) from convincing to weak according to established criteria. Quality was assessed with the Assessment of Multiple Systematic Reviews 2 (AMSTAR-2) tool.
RESULTS: Of 2,197 meta-analyses, nine were included, providing evidence on 50 risk factors, 29,272 subjects with eating disorders, and 1,679,385 controls. Although no association was supported by convincing evidence, highly suggestive evidence supported the association between childhood sexual abuse and bulimia nervosa (k = 29, 1,103 cases with eating disorders, 8,496 controls, OR, 2.73, 95%CI 1.96-3.79, p = 2.1 x 10-9, AMSTAR-2 moderate quality) and between appearance-related teasing victimization and any eating disorder (k = 10, 1,341 cases with eating disorders, 3,295 controls, OR 2.91, 95%CI 2.05-4.12, p = 1.8x10-9, AMSTAR-2 moderate quality). Suggestive, weak, or no evidence supported 11, 29, and 8 associations, respectively.
CONCLUSIONS: The most credible evidence indicates that early traumatic and stressful events are risk factors for eating disorders. Larger collaborative prospective cohort studies are needed to identify risk factors for eating disorders, particularly anorexia nervosa.

Entities:  

Year:  2020        PMID: 32997075      PMCID: PMC8136381          DOI: 10.1590/1516-4446-2020-1099

Source DB:  PubMed          Journal:  Braz J Psychiatry        ISSN: 1516-4446            Impact factor:   2.697


Introduction

Eating disorders (ED) are a complex group of psychiatric disorders characterized by psychopathology which results in pathological eating behaviors that can lead to medical complications.1 For example, people with anorexia nervosa (AN) are approximately five times more likely to die from any cause and eighteen times more likely to die from suicide than the general population.2,3 In addition, bulimia nervosa (BN) and binge eating disorders (BED) are associated with complications of vomiting, laxative abuse, and obesity, respectively. ED outcomes have remained poor in recent decades, with high rates of chronicity,4-6 which could suggest a lack of understanding about the underlying pathophysiological mechanisms that lead to ED onset and persistence. For example, the lack of efficacious pharmacological interventions specifically for AN might be due to a relative lack of insight about the biological mechanisms underlying it.7-9 The fact that there is no clearly superior psychosocial intervention among a wide range of interventions for adults and adolescents with AN is also particularly concerning.10 Despite the poor mechanistic knowledge of ED, an extensive body of literature has investigated putative risk factors for ED, testing a wide range of environmental11-15 and genetic16-20 risk factors. However, the contrasting results of individual studies are frequently not confirmed in meta-analysis. A recent large collaborative genome-wide association study has shown that metabo-psychiatric genetic predisposition, specifically eight previously unidentified loci, might increase the risk of AN.21 Poor knowledge of the mechanistic processes that lead to ED and risk factors for ED might be one of the reasons why early ED intervention and prevention has been studied less than psychotic and other non-psychotic disorders.22,23 Despite preliminary evidence suggesting the potential efficacy of ED prevention, more evidence synthesis is needed,24,25 since the state of the art for evidence on interventions to prevent or delay ED onset seems to be relatively less explored than in other fields of psychiatry.26,27 Although the prevention of mental disorders, particularly psychosis, is being explored, it has only been partially implemented worldwide. The results so far have shown that the pre-assessment of risk should be improved to find subjects actually at risk of developing mental disorders.28-32 Since preventive interventions are not free from potential side effects, they must be performed only for individuals with an epidemiologically and clinically significant risk of any mental illness.33 Putative risk factors, whose associations have been inflated by biased results, must be replaced with convincing ones, as is being done for several other mental disorders, including schizophrenia,34,35 autism,36,37 depression,38 bipolar disorder,39 post-traumatic stress disorder,40 anxiety spectrum disorder and obsessive compulsive disorder.41 This a necessary step for finding individuals who might be at risk of ED and could thus benefit from preventive interventions. Therefore, the aim of the present umbrella review, which graded evidence through a systematic review of meta-analyses, identified quantitative criteria based on additional statistical tests, and re-calculated each meta-analytic association, was to grade the available evidence on risk factors for ED, identifying those that should be targeted in ED prevention and considered when assessing a person with subthreshold symptoms.

Methods

A protocol for this study is publicly available on the Center for Open Science platform (https://osf.io/hu8yd/?view_only=269352b4b1e040bcb825f48b567032a4). We performed a systematic review, considering the Preferred Reporting Items for Systematic Reviews and Meta-analyses42 and the Meta-analysis of Observational Studies in Epidemiology guidelines.43

Search strategy and selection criteria

We searched the PubMed, PsycInfo and Embase databases (final search on December 11th, 2019) to identify systematic reviews with meta-analyses pooling longitudinal observational studies that examined any association between putative risk factors for ED, defined according to clinical records, any version of the DSM or ICD, or validated scales with cut-off points. The following keywords were used in PubMed (meta-analysis OR meta-analysis OR systematic review) AND (anorexia nervosa OR binge* OR bulimi* OR eating disorder*), and equivalent ones were used in PsycInfo and Embase. Two reviewers (DM, DB) independently searched the titles/abstracts for eligibility and assessed the full text of articles that passed this phase. A third reviewer (MS) resolved any conflicts. When more than one meta-analysis assessed the same risk factor, we only included the one with the most studies, as previously described.34,38,39,44,45 The exclusion criteria were: 1) meta-analyses of randomized controlled trials; 2) those published in languages other than English; 3) those that included cross-sectional studies from which no causal inference could be made; 4) systematic reviews without meta-analyses. The same two investigators who independently performed the screening extracted the data in a predefined Excel spreadsheet. For each meta-analysis, we extracted the PMID/DOI, first author, publication year, population, risk factor, study design, ED type (AN, BN, BED, or mixed), number of included studies and total sample size to identify the largest meta-analysis. For each primary study in the largest meta-analyses, we recorded data on the first author, year of publication, study design, number of cases (subjects who developed ED), subjects who did not develop ED, effect size with 95% confidence intervals (95%CI), ED definition criteria, and study location. The methodological quality of each included meta-analysis was assessed with the Assessment of Multiple Systematic Reviews (AMSTAR) 2 tool (a recent update of AMSTAR,46 available at https://amstar.ca/Amstar-2.php) by the same two investigators.

Data analysis

For each association in each meta-analysis, we re-performed a random-effect meta-analysis that calculated the pooled effect size and the 95% confidence intervals.47 Heterogeneity was assessed with the I2 statistic.48 We calculated the 95% prediction intervals for the summary random effect sizes, which provide the possible range in which the effect sizes of future studies are expected to fall.49 We also tested for the presence of small-study effect bias,38,39,44,50 which was deemed to be present in cases of pooled estimates larger than the largest individual study, as well as publication bias (Egger’s regression asymmetry test [p ≤ 0.10]). Finally, we assessed excess significance bias by evaluating whether the observed number of studies with nominally statistically significant results (p ≤ 0.05) were different from the expected number of studies with statistically significant results (significance threshold set at p ≤ 0.10).51,52

Grading the evidence

The credibility of the meta-analyses was assessed according to stringent criteria based on previously published umbrella reviews.38,39,44,50,53 In brief, associations that presented nominally significant random-effects summary effect sizes (i.e., p < 0.05) were ranked as convincing, highly suggestive, suggestive, or weak evidence based on the number of events, the strength of the association, and the presence of several biases (criteria presented in Box 1). The quality of included meta-analyses was assessed with the AMSTAR-2 tool.
Box 1

Credibility assessment criteria for meta-analyses of observational studies

ClassificationCriteria
Convincing evidence (Class I)1. More than 1,000 cases2. Significant summary associations (p < 10-6) per random-effects calculations3. No evidence of small-study effects4. No evidence of excess of significance bias5. Prediction intervals not including the null value6. Largest study nominally significant (p < 0.05)7. Not large heterogeneity (i.e., I2 < 50%)
Highly suggestive evidence (Class II)1. More than 1,000 cases2. Significant summary associations (p < 10-6) per random-effects calculation3. Largest nominally significant study (p < 0.05)
Suggestive evidence (Class III)1. More than 1,000 cases2. Significant summary associations (p < 10-3) according to random effect calculations
Weak evidence1. All other associations with p < 0.05
Non-significant associations1. All associations with p < 0.05

Results

Search

A flowchart of the search, selection and inclusion process is presented in Figure 1. Out of 2,197 articles screened at the title/abstract level, we assessed the full text of 45 publications. Of these, 36 were excluded for including only cross-sectional studies (n=26), not conducting a meta-analysis of risk factors for ED (n=4), not being the largest meta-analysis (n=3), not focusing on ED as defined according to the inclusion criteria of the present umbrella review (n=2), or performing a pooled, rather than a meta-analysis (n=1). A reference list of the 36 excluded articles is provided in Table S1, available as online-only supplementary material. Nine meta-analyses were ultimately included, providing evidence on 49 risk factors from a total of 29,272 individuals with ED and 1,679,385 controls.
Figure 1

Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) flowchart.

The evidence grade for ED risk factors is reported in Table 1. Nine meta-analyses11,12,54-60 investigated a wide range of risk factors for ED. Early menarche was investigated in one meta-analysis, peripartum events were investigated in four (APGAR score, C-section, vaginal instrumental delivery, and gestational age lower than 37 weeks), pre-existing medical or psychiatric conditions were investigated in seven (attention deficit and hyperactivity disorder, substance use, type I diabetes), initial psychological features and BMI at baseline assessment in longitudinal studies were investigated in nine, and the remaining investigated risk factors were lifetime or childhood traumatic events or physical, emotional, sexual abuse.
Table 1

Evidence grading for meta-analyses of observational studies on risk factors for ED

StudyStudy designRisk factorED typeED definitionkGrading of evidenceAMSTAR-2eOR
Caslini 201654 Case-controlChildhood sexual abuseBNDSM-III32Highly suggestiveModerate2.73
Lie 201957 Case-controlAppearance-related teasing victimizationEDDSM-III, DSM-IV, ICD-1010Highly suggestiveModerate2.91
Caslini 201654 Case-controlChildhood sexual abuseBEDDSM-IV32SuggestiveModerate2.31
Caslini 201654 Case-controlChildhood physical abuseBEDDSM-IV32SuggestiveModerate3.10
Krug 201355 Case-controlAPGAR score at 5 minutes < 7ANICD-96SuggestiveModerate1.32
Nazar 201656 CohortADHDEDDSM-IV17SuggestiveModerate4.24
Nazar 201656 CohortADHDEDDSM-IV17SuggestiveModerate4.21
Nazar 201656 CohortADHDBEDClinical interview17SuggestiveModerate3.93
Stice 200211 CohortInitial body dissatisfactionEDEDINASuggestiveModerate1.67
Stice 200211 CohortInitial self-reported dietingBNEDINASuggestiveModerate2.26
Stice 200211 CohortInitial negative affectEDEDINASuggestiveModerate1.38
Stice 200211 CohortInitial perceived pressure to be thinEDEDINASuggestiveModerate1.51
Caslini 201654 Case-controlChildhood sexual abuseANDSM-IV32WeakModerate1.92
Caslini 201654 Case-controlPhysical abuseANDSM-IV32WeakModerate3.35
Caslini 201654 Case-controlPhysical abuseBNDSM-IV32WeakModerate3.44
Chen 201012 Case-controlSexual abuseEDClinical interview37WeakModerate2.72
Lie 201957 Case-controlBullying victimizationEDDSM-III, DSM-IV, ICD-106WeakModerate2.22
Molendijk 201758 Case-controlSexual abuseANDSM-III-R82WeakModerate1.74
Molendijk 201758 Case-controlSexual abuseAN BPDSM-III-R82WeakModerate2.80
Molendijk 201758 Case-controlSexual abuseBEDDSM-IV82WeakModerate1.88
Molendijk 201758 Case-controlSexual abuseBNDSM-III-R82WeakModerate2.48
Molendijk 201758 Case-controlSexual abuseEDDSM-IV82WeakModerate2.29
Molendijk 201758 Case-controlPhysical abuseAN BPDSM-IV82WeakModerate2.76
Molendijk 201758 Case-controlPhysical abuseAN RDSM-IV82WeakModerate2.65
Molendijk 201758 Case-controlPhysical abuseBEDDSM-IV82WeakModerate2.57
Molendijk 201758 Case-controlPhysical abuseBNDSM-IV82WeakModerate3.43
Molendijk 201758 Case-controlPhysical abuseEDDSM-IV82WeakModerate2.96
Molendijk 201758 Case-controlEmotional abuseAN RDSM-IV82WeakModerate3.52
Molendijk 201758 Case-controlEmotional abuseBEDDSM IV82WeakModerate2.44
Molendijk 201758 Case-controlEmotional abuseBNDSM-III-R82WeakModerate5.13
Molendijk 201758 Case-controlDouble abuseEDDSM-III-R82WeakModerate2.09
Nazar 201656 CohortADHDEDDSM-IV17WeakModerate3.33
Stice 200211 CohortInitial modeling of body imageBEDEDE QNAWeakModerate1.81
Stice 200211 CohortInitial thin ideal internalizationBEDBULIT R, EAT 26NAWeakModerate1.51
Stice 200211 CohortInitial perfectionismBNEDINAWeakModerate1.24
Stice 200211 CohortImpulsivityBEDBULIT R, EAT 26NAWeakModerate1.28
Stice 200211 CohortSubstance useBNDSM-III-RNAWeakModerate1.44
Stice 200211 CohortInitial BMIBNEDINAWeakModerate1.67
Young 201359 CohortDiabetes type IBNEAT-26NAWeakCritically low1.94
Young 201359 CohortDiabetes type IEDDSM-IVNAWeakCritically low2.30
Krug 201355 Case-controlVaginal instrumental deliveryANICD-96No evidenceModerate1.07
Krug 201355 Case-controlGestational age < 37 weeksANICD-96No evidenceModerate0.80
Lie 201957 Case-controlAppearance-unrelated teasing victimizationEDDSM-III, DSM-IV, ICD-106No evidenceModerate1.5
Molendijk 201758 Case-controlSexual abuseAN RDSM-III-R82No evidenceModerate1.65
Molendijk 201758 Case-controlPhysical abuseANDSM-III-R82No evidenceModerate1.23
Molendijk 201758 Case-controlSexual abuseEDDSM-III-R82No evidenceModerate1.29
Stice 200211 CohortEarly menarcheEDEAT 26NANo evidenceModerate1.19
Zhang 201960 Case-controlCaesarean deliveryEDICD-9, ICD-104No evidenceHigh1.18

ADHD = attention deficit hyperactivity disorder; AMSTAR = Assessment of Multiple Systematic Reviews; AN = anorexia nervosa; BED = binge eating disorder; BMI = body mass index; BN = bulimia nervosa; BULIT R = Bulimia Test; EAT = Eating Attitude Test; ED = eating disorders; EDE Q = Eating Disorder Examination Questionnaire; EDI = Eating Disorders Inventory; eOR = equivalent odds ratio; NA = not available; OR = odds ratio; PI = prediction interval.

Overall, no association was supported by convincing evidence. Highly suggestive evidence supported the association between childhood sexual abuse and BN (k = 29, 1,103 ED cases, 8,496 controls, OR, 2.73, 95%CI 1.96-3.79, p = 2.1 x 10-9, AMSTAR-2 moderate quality)54 and between appearance-related teasing victimization and any ED (k = 10, 1,341 ED cases, 3,295 controls, OR 2.91, 95%CI 2.05-4.12, p = 1.8 x 10-9, AMSTAR-2 moderate quality).57 Suggestive, weak, or no evidence was provided for 10, 29, and 8 risk factor, respectively. More specifically, the 12 meta-analyses that investigated risk factors for AN had the lowest evidence among all ED (one provided suggestive evidence, seven provided weak evidence, and four provided no evidence). Ten meta-analyses investigated risk factors for BED (three provided suggestive evidence and seven provided weak evidence). Ten meta-analyses investigated BN (one provided highly suggestive evidence, one provided suggestive evidence, and eight provided weak evidence). The remaining 17 meta-analyses investigated risk factors for any ED (one provided highly suggestive evidence, five provided suggestive evidence, seven provided weak evidence, and four provided no evidence). The median number of studies per meta-analysis was 32 (interquartile range [IQR] 17-82). The median number of ED cases per risk factor was 514 (IQR 196-1,103), and the median total population was 3,147 (IQR 993-8,478). Detailed sources of bias are reported in Table 2 for all significant associations. Overall, the following bias pattern emerged: associations based on evidence from at least 1,000 subjects with ED (18%), 95% prediction intervals excluding the null value (18%), small study effect absent (72%), excess significance bias absent (60%), low overall heterogeneity of associations (8% with significant heterogeneity), significance of the largest study (68%), and publication bias (70%). The quality of included meta-analyses was high for one,60 critically low for one,59 and moderate for the reaming seven.
Table 2

Grading criteria for highly suggestive, suggestive, and weak evidence of risk factors for eating disorders

StudyRisk factorkCasesNon casesTotalAbove1,000 casesHeterogeneityPI includes nullp-value ES* Egger’s testLargest study significantSmall study effectExcess of significance biasClass of evidenceES typeES95% low CI95% upper CI
Caslini 201654 Childhood sexual abuse261,1037,3938,496111101002OR2.731.963.79
Lie 201957 appearance-related teasing victimization101,3411,9543,295111101002OR2.912.054.12
Caslini 201654 Childhood physical abuse4NANANANA001010NA3OR3.102.483.88
Caslini 201654 Childhood sexual abuse7NANANANA001010NA3OR2.311.663.20
Krug 201355 APGAR score at 5 minutes < 7332,70165,44368,144100200013OR1.321.171.49
Nazar 201656 ADHD123,61823,39827,016111110113OR4.242.626.87
Nazar 201656 ADHD61,8147,7099,523111201003OR4.212.227.97
Nazar 201656 ADHD41,2637,1638,426111201003OR3.932.097.38
Stice 200211 Initial body dissatisfaction11NANA17,332NA111010NA3r0.140.110.17
Stice 200211 Initial negative affect11NANA17,411NA11101013r0.090.060.12
Stice 200211 Initial perceived pressure to be thin4NANA7,517NA011010NA3r0.110.080.14
Stice 200211 Initial self-reported dieting7NANA9,436NA11111113r0.220.140.30
Caslini 201654 Childhood sexual abuse131962,2642,460011310104OR1.921.133.27
Caslini 201654 Emotional abuse2NANANANA0NA2NA1NANA4OR3.692.076.59
Caslini 201654 Physical abuse4301,0241,054001300004OR3.351.437.85
Caslini 201654 Physical abuse92221,9062,128000111114OR3.442.564.60
Chen 201012 Sexual abuse1129213,03513,327000101004OR2.722.043.63
Lie 201957 Bullying victimization65549111,465000201004OR2.221.503.28
Molendijk 201758 Double abuse31254,3934,518001300004OR2.091.323.30
Molendijk 201758 Emotional abuse3129159288001300004OR3.521.687.38
Molendijk 201758 Emotional abuse34372,2882,725001101004OR2.441.733.48
Molendijk 201758 Emotional abuse2611,3791,44000NA1NA1004OR5.132.809.39
Molendijk 201758 Physical abuse483218301001300004OR2.761.445.29
Molendijk 201758 Physical abuse6176333509001301004OR2.651.335.28
Molendijk 201758 Physical abuse55912,5563,147000101004OR2.571.993.30
Molendijk 201758 Physical abuse95141,8532,367010110114OR3.432.195.39
Molendijk 201758 Physical abuse7521172693000101004OR2.961.894.62
Molendijk 201758 Sexual abuse73141,7702,084011300004OR1.741.092.79
Molendijk 201758 Sexual abuse6175341516011300014OR2.801.236.36
Molendijk 201758 Sexual abuse55912,5563,147001201004OR1.881.382.55
Molendijk 201758 Sexual abuse189973,9694,966011211104OR2.481.703.60
Molendijk 201758 Sexual abuse7521172693001301004OR2.291.363.87
Nazar 201656 ADHD31,1746,9548,128111301004OR3.331.397.97
Stice 200211 Initial BMI10NANA11,063NA112101NA4r0.140.060.22
Stice 200211 Impulsivity3NANA933NA01300014r0.070.000.13
Stice 200211 Initial modeling of body image2NANA449NA0NA3NA1NANA4r0.160.070.25
Stice 200211 Initial perfectionism4NANA2,124NA01301004r0.060.020.10
Stice 200211 Initial thin ideal internalization4NANA15,182NA113010NA4r0.110.040.20
Stice 200211 Substance use4NANA2,236NA01201004r0.100.060.14
Young 201359 Diabetes9NANA927NA11301014d0.360.130.60
Young 201359 Diabetes7NANA4,515NA11310104d0.460.100.82

ADHD = attention deficit hyperactivity disorder; CI = confidence interval; NA = not available; OR = odds ratio; PI = prediction interval.

1 ≤ 10-6, 2 ≤ 10-3, 3 ≤ 0.05, 4 ≤ 0.05.

Discussion

This is the first comprehensive umbrella review of meta-analyses on risk factors for ED, which goes beyond mere pooling of available meta-analyses by including additional stringent statistical tests and evidence grading based on quantitative criteria. This review included 50 associations from nine meta-analyses, showing a lack of convincing evidence supporting all ED risk factors. Highly suggestive evidence was found for childhood sexual abuse as risk factor for BN and appearance-related teasing victimization for any ED. These results can advance clinical knowledge in the field of ED on various points. First, none of the putative risk factors for ED are supported by convincing evidence, and several types of bias may have inflated the estimates reported in meta-analyses. This is particularly concerning when we compare the evidence of risk factors for ED with the evidence of risk factors for schizophrenia34,35 (seven factors overall supported by convincing evidence), autism36,37 (seven factors), depression38 (eight factors), bipolar disorder39 (one factor), post-traumatic stress disorder40 (three factors), and anxiety spectrum disorder and obsessive compulsive disorder41 (one). Environmental factors play an important role in the pathogenesis of mental disorders, while genetic predisposition still explains only a very small portion of the risk of schizophrenia, depressive disorders, bipolar disorders.61 The lack of established risk factors for ED may be due to limited research in this field or to the heterogeneity of the clinical pictures, which have common characteristics and frequent overlap with other mental disorders. There are common general psychopathologic features in ED (e.g., depressive, anxious, obsessive-compulsive), as well as feelings of ineffectiveness and interpersonal sensitivity, which appear to be even more central than behavioral and specific psychopathologies.62 This could reduce the specificity of risk factors. Second, while a number of mental disorders have specific risk factors, such as high clinical risk for psychosis,34 or irritable bowel syndrome for bipolar disorder,39 the risk factors for ED found in the present review appear to be relatively unspecific. For example, childhood sexual abuse has been connected with a number of adverse health outcomes, including borderline personality disorder, anxiety, depression, post-traumatic stress disorder, psychosis, and non-suicidal self-injury, in addition to pain, risky sexual behavior, obesity, and HIV infection.63 This is not surprising, given that child abuse is a risk factor for general psychopathology64 and that the effect of sexual abuse on ED psychopathology is probably mediated by ineffectiveness, which is present beyond ED.65 The transdiagnostic nature of these risk factors is relatively underexplored but could, at least theoretically, allow transdiagnostic early detection and intervention for these disorders.66,67 To the best of our knowledge, only one pooled analysis of follow-up data from three randomized controlled trials on ED prevention has focused on a high-risk population with body dissatisfaction, finding that negative affect and low BMI predicted AN, elevated body dissatisfaction, overeating, and fasting predicted BN, and elevated body dissatisfaction, overeating, and functional impairment predicted BED.68 However, such findings have not yet been replicated in larger cohort studies and have not been pooled in meta-analyses accounting for random error and heterogeneity across studies. Moreover, one more reason for the lack of evidence about risk factors for ED might be explained by a recent large GWAS study, which included 16,992 cases of anorexia nervosa and 55,525 controls, finding that eight loci linked to other psychiatric disorders, physical activity, and metabolic (including glycemic), lipid and anthropometric traits (independent of the effects of common variants associated with body-mass index) were associated with a higher risk of AN.21 Such results might suggest that some genetic risk is shared with other psychiatric conditions, but that there are also specific metabolic pathways for AN that should be investigated in greater detail. However, an overlap between mental and physical disorders is also present in other mental disorders.69 Third, we found that the least evidence is available for AN, which is, on the other hand, the most severe ED in terms of clinical outcome, medical complications, and survival. Fourth, the lack of clear evidence supporting the identification of ED risk factors, especially for AN, is highly relevant in the light of the need for early ED detection as a crucial component in improving ED treatment efficacy. Some authors70 have proposed a staging model for AN that shows poorer outcomes with illness progression. In line with this framework, the NICE (2010) ED guidelines recommend that treatment should begin at the earliest opportunity to avoid the additional effects of chronicity, psychiatric comorbidity, and complications from malnutrition.71 Promoting mental health, a complementary strategy for preventing mental disorders, is particularly needed in young populations, such as those at risk of developing ED.72 Appearance-related teasing victimization was identified as a risk factor for any ED, with highly suggestive, but not convincing, evidence. This confirms that interpersonal and social functioning might be a risk factor for ED, which was suggested in a systematic review73 that highlighted the role of interpersonal issues as a factor in ED onset. In addition, this finding confirms that emotional abuse in childhood and adolescence, which consists of humiliating and demeaning experiences, is the form of abuse most directly associated with ED psychopathology, independent of other psychiatric comorbidities.74 The strength of the present study is that it is the first umbrella review to demonstrate that no convincing evidence supports any ED risk factor. Moreover, it provides methodological direction for future studies, i.e., a focus on high quality evidence about ED risk factors, such as large-scale collaborative studies, harmonizing measurements, and data sharing to bridge the gap with prevention strategies implemented in other areas of psychiatry. Finally, the focus of collaborative studies should be on metabolic pathways, which were associated with AN in a large recent GWAS study. Thus, leading centers involved clinical research on ED should plan large multicenter longitudinal cohort studies investigating the role of putative risk factors for ED, focusing on metabolic pathways, which have been completely neglected to date. The main limitation of the present study is that only one of the included meta-analyses met high quality criteria according to the AMSTAR-2 checklist. Furthermore, the lack of evidence for specific risk factors could be related to the paucity of large-scale collaborative longitudinal studies assessing the role of moderating mechanisms in the relationship between conditions preceding the onset of the disorder and the development of ED psychopathology.75 Finally, factors not included in meta-analyses are not considered in umbrella reviews. In conclusion, no ED risk factor is supported by convincing evidence. The field of ED is being left behind with respect to the preliminary evidence necessary to begin implementing targeted preventive interventions for individuals with subthreshold symptoms. More multi-center longitudinal cohort studies are needed to identify modifiable risk factors for ED, including the metabolic factors suggested by a recent large-scale GWAS study.21

Disclosure

The authors report no conflicts of interest.
  73 in total

Review 1.  Eating disorder prevention: current evidence-base and future directions.

Authors:  Eric Stice; Carolyn Black Becker; Sonja Yokum
Journal:  Int J Eat Disord       Date:  2013-07       Impact factor: 4.861

Review 2.  Has the time come for a staging model to map the course of eating disorders from high risk to severe enduring illness? An examination of the evidence.

Authors:  Janet Treasure; Daniel Stein; Sarah Maguire
Journal:  Early Interv Psychiatry       Date:  2014-09-29       Impact factor: 2.732

3.  Risk factors that predict future onset of each DSM-5 eating disorder: Predictive specificity in high-risk adolescent females.

Authors:  Eric Stice; Jeff M Gau; Paul Rohde; Heather Shaw
Journal:  J Abnorm Psychol       Date:  2016-10-06

Review 4.  The use of polygenic risk scores to identify phenotypes associated with genetic risk of bipolar disorder and depression: A systematic review.

Authors:  Sumit Mistry; Judith R Harrison; Daniel J Smith; Valentina Escott-Price; Stanley Zammit
Journal:  J Affect Disord       Date:  2018-02-15       Impact factor: 4.839

Review 5.  Serotonin transporter gene polymorphism in eating disorders: Data from a new biobank and META-analysis of previous studies.

Authors:  M Solmi; D Gallicchio; E Collantoni; C U Correll; M Clementi; C Pinato; M Forzan; M Cassina; F Fontana; V Giannunzio; I Piva; R Siani; P Salvo; P Santonastaso; E Tenconi; N Veronese; A Favaro
Journal:  World J Biol Psychiatry       Date:  2016-02-19       Impact factor: 4.132

Review 6.  Psychotropic drug treatment in anorexia nervosa. Search for differences in efficacy/tolerability between adolescent and mixed-age population.

Authors:  Matteo Balestrieri; Maria Ginevra Oriani; Annalisa Simoncini; Cesario Bellantuono
Journal:  Eur Eat Disord Rev       Date:  2013-06-04

Review 7.  What is good mental health? A scoping review.

Authors:  Paolo Fusar-Poli; Gonzalo Salazar de Pablo; Andrea De Micheli; Dorien H Nieman; Christoph U Correll; Lars Vedel Kessing; Andrea Pfennig; Andreas Bechdolf; Stefan Borgwardt; Celso Arango; Therese van Amelsvoort
Journal:  Eur Neuropsychopharmacol       Date:  2019-12-31       Impact factor: 4.600

8.  Deconstructing Pretest Risk Enrichment to Optimize Prediction of Psychosis in Individuals at Clinical High Risk.

Authors:  Paolo Fusar-Poli; Grazia Rutigliano; Daniel Stahl; André Schmidt; Valentina Ramella-Cravaro; Shetty Hitesh; Philip McGuire
Journal:  JAMA Psychiatry       Date:  2016-12-01       Impact factor: 21.596

9.  AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both.

Authors:  Beverley J Shea; Barnaby C Reeves; George Wells; Micere Thuku; Candyce Hamel; Julian Moran; David Moher; Peter Tugwell; Vivian Welch; Elizabeth Kristjansson; David A Henry
Journal:  BMJ       Date:  2017-09-21

Review 10.  eHealth interventions for the prevention of depression and anxiety in the general population: a systematic review and meta-analysis.

Authors:  M Deady; I Choi; R A Calvo; N Glozier; H Christensen; S B Harvey
Journal:  BMC Psychiatry       Date:  2017-08-29       Impact factor: 3.630

View more
  9 in total

1.  Management of eating disorders for people with higher weight: clinical practice guideline.

Authors:  Angelique F Ralph; Leah Brennan; Sue Byrne; Belinda Caldwell; Jo Farmer; Laura M Hart; Gabriella A Heruc; Sarah Maguire; Milan K Piya; Julia Quin; Sarah K Trobe; Andrew Wallis; A J Williams-Tchen; Phillipa Hay
Journal:  J Eat Disord       Date:  2022-08-18

Review 2.  Methodological approaches for assessing certainty of the evidence in umbrella reviews: A scoping review.

Authors:  Saranrat Sadoyu; Kaniz Afroz Tanni; Nontaporn Punrum; Sobhon Paengtrai; Warittakorn Kategaew; Nattiwat Promchit; Nai Ming Lai; Ammarin Thakkinstian; Surachat Ngorsuraches; Mukdarut Bangpan; Sajesh Veettil; Nathorn Chaiyakunapruk
Journal:  PLoS One       Date:  2022-06-08       Impact factor: 3.752

3.  Young Patients with Anorexia Nervosa: The Contribution of Post-Traumatic Stress Disorder and Traumatic Events.

Authors:  Paola Longo; Enrica Marzola; Carlotta De Bacco; Matilde Demarchi; Giovanni Abbate-Daga
Journal:  Medicina (Kaunas)       Date:  2020-12-22       Impact factor: 2.430

4.  The connection between childhood maltreatment and eating disorder psychopathology: a network analysis study in people with bulimia nervosa and with binge eating disorder.

Authors:  Alessio Maria Monteleone; Orna Tzischinsky; Giammarco Cascino; Sigal Alon; Francesca Pellegrino; Valeria Ruzzi; Yael Latzer
Journal:  Eat Weight Disord       Date:  2021-03-28       Impact factor: 4.652

5.  Thirty years of research on physical activity, mental health, and wellbeing: A scientometric analysis of hotspots and trends.

Authors:  Michel Sabe; Chaomei Chen; Othman Sentissi; Jeroen Deenik; Davy Vancampfort; Joseph Firth; Lee Smith; Brendon Stubbs; Simon Rosenbaum; Felipe Barreto Schuch; Marco Solmi
Journal:  Front Public Health       Date:  2022-08-09

6.  Aldehyde dehydrogenase 2 rs671 polymorphism and multiple diseases: protocol for a quantitative umbrella review of meta-analyses.

Authors:  Zhengting He; Qi Guo; Yikai Ling; Chuan Hong; Yuqing Liu; Xurui Jin; Porama Thanaporn; Duan Zhao; Leiting Wang; Liang Liu; Lijing L Yan
Journal:  Syst Rev       Date:  2022-09-02

7.  Trauma exposure and eating disorders: Results from a United States nationally representative sample.

Authors:  Alexandra D Convertino; Leslie A Morland; Aaron J Blashill
Journal:  Int J Eat Disord       Date:  2022-06-19       Impact factor: 5.791

8.  Validity of observational evidence on putative risk and protective factors: appraisal of 3744 meta-analyses on 57 topics.

Authors:  Perrine Janiaud; Arnav Agarwal; Ioanna Tzoulaki; Evropi Theodoratou; Konstantinos K Tsilidis; Evangelos Evangelou; John P A Ioannidis
Journal:  BMC Med       Date:  2021-07-06       Impact factor: 11.150

Review 9.  Obesity and Eating Disorders in Children and Adolescents: The Bidirectional Link.

Authors:  Stella Stabouli; Serap Erdine; Lagle Suurorg; Augustina Jankauskienė; Empar Lurbe
Journal:  Nutrients       Date:  2021-11-29       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.